article thumbnail

Redefining Acceleration of the Drug Development Journey

PPD

It is hard to ignore some of the most pressing, long-term trends driving the push to accelerate innovation and progress in drug development. According to the United Nation’s 2024 World Population Prospects data, the global population of those 65 years old and over will grow from 0.8 billion in 2023 to 1.2 billion in 2035.

article thumbnail

How to Develop a Sustainable Generic Drug Development Strategy

Drug Patent Watch

This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. Pfizer, for example, has been applying green chemistry principles in drug development for over two decades to reduce waste, minimize resource use, and develop energy-efficient manufacturing processes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Discovery Industry Roundup with Barry Bunin — July, 22 2024

Collaborative Drug

Is Revolutionizing Drug Development. Holy Grail for Weight-Loss Drugs Is Sleep Apnea? DNA Discovery that Could Help Find Pancreatic Cancer Cure.

DNA 263
article thumbnail

Key Trends Drug Developers Need to Know to Succeed

PPD

As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.

article thumbnail

The Real Cost of Complexity: What Every Drug Developer Needs to Know

PPD

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

article thumbnail

Sentiment & Themes Emerging From JPM 2024

LifeSciVC

Whether trial design, execution, or otherwise, drug development even where there is precedent is a challenging road and should not be taken for granted. Let’s agree to make 2024 the year we take action and voice concerns for legislation that encumbers the ability for biotech to deliver on its promise to patients and caregivers.

article thumbnail

#ScienceSaturday: March 2, 2024

KIF1A

The Jackson Laboratory is offering a short MiniCourse on modeling rare diseases for preclinical drug development. The Jackson Laboratory has been integral in the development of KAND cell and mouse models, and we’re grateful for their continued dedication to advancing rare disease research.